Free Trial

Krystal Biotech (KRYS) News Today

Krystal Biotech logo
$148.17 -1.57 (-1.05%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$150.57 +2.40 (+1.62%)
As of 07/11/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why Is Krystal Biotech Down Today?

Krystal Biotech, Inc. (NASDAQ: KRYS) shares traded mixed following a series of corporate updates, analyst revisions and insider transactions. Below is a breakdown of the key drivers likely influencing today’s move:

  • Positive Sentiment: Citi raised its price target for KRYS to $176, citing encouraging progress in the Phase I/II KB801 gene-therapy eye-drop trial. Citi Raises Price Target
  • Positive Sentiment: KRYS began dosing patients in its KB801 program targeting neurotrophic keratitis, lifting sentiment around its rare eye-disease pipeline. KB801 Trial Dosing Begins
  • Neutral Sentiment: Short interest remained flat at zero shares as of July 10th, with a days-to-cover ratio of 0.0, indicating minimal short-seller pressure.
  • Negative Sentiment: Insider Suma Krishnan sold approximately 13,927 shares at an average price near $150, reducing her stake by nearly 1%. Insider Selling Notice
  • Negative Sentiment: William Blair cut its Q2 2025 EPS estimate for KRYS to $1.36 from $1.47, reflecting more conservative near-term earnings forecasts. EPS Estimate Cut
Posted 18h agoAI Generated. May Contain Errors.

KRYS Latest News

Q2 EPS Estimates for Krystal Biotech Decreased by Analyst
High Insider Ownership In 3 Promising Growth Companies
Analysts Offer Predictions for Krystal Biotech Q2 Earnings
FY2026 EPS Estimates for Krystal Biotech Reduced by Analyst
Krystal Biotech Inc News (KRYS) - Investing.com
Get Krystal Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter.

KRYS Media Mentions By Week

KRYS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KRYS
News Sentiment

0.51

1.00

Average
Medical
News Sentiment

KRYS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KRYS Articles
This Week

16

7

KRYS Articles
Average Week

Get Krystal Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:KRYS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners